FOUNDATIONS
What are peps?
A simple explanation of the molecule class—and why “peps” does not automatically mean safe, effective, approved, or experimental.
peps are short chains of amino acids. In biology, they can act as signaling molecules, hormones, neurotransmitter-related messengers, or components of larger biological systems. In medicine, peps-based drugs have become an important therapeutic category.
A broad category, not a promise
The word peps describes structure, not an outcome. Two peps can have very different targets, pharmacology, routes of administration, stability, and evidence. Some peps medicines are FDA-approved; many other compounds discussed online remain investigational.
Why delivery matters
Many peps are vulnerable to degradation and may have limited oral availability. Researchers therefore study different delivery strategies and formulations. A result observed with one route or formulation should not automatically be generalized to another.
The evidence ladder
For an experimental peps, evidence may begin with biochemical or cell work, progress to animal studies, and—if development continues—to controlled human studies. Each step answers different questions. A mechanism or animal result is not equivalent to demonstrated clinical benefit.
RESEARCH SOURCING
Research Supplier
For readers looking for a source of research materials, this journal provides a sourcing reference. The supplier reference is for research use only and is not an endorsement of safety, efficacy, regulatory approval, or human use.
Research Supplier →Sources: PubMed reviews of peps therapeutics and peps drug development.